ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Poseida Awarded $19.8 Million CIRM Grant to Support Clinical Trial of P-BCMA-101, a T Stem Cell Memory CAR-T … – GlobeNewswire (press release)

Poseida Awarded $19.8 Million CIRM Grant to Support Clinical Trial of P-BCMA-101, a T Stem Cell Memory CAR-T …GlobeNewswire (press release)SAN DIEGO, Oct. 26, 2017 (GLOBE NEWSWIRE) — Poseida Therapeutics Inc. (“Poseida”), a San Diego-based company t… Continue reading

2017-10-26 Michael Zand NEWS

UW Team Combines CRISPR With Duplex Sequencing to Detect Low-Frequency Mutations – GenomeWeb

UW Team Combines CRISPR With Duplex Sequencing to Detect Low-Frequency MutationsGenomeWebSAN FRANCISCO (GenomeWeb) – Researchers from the University of Washington have developed a targeted sequencing method that couples the CRISPR/Cas9 system for targe… Continue reading

2017-10-26 Michael Zand NEWS

Melanoma Exomes Implicate Antigen-Related Gene Changes in Immunotherapy Resistance – GenomeWeb

Melanoma Exomes Implicate Antigen-Related Gene Changes in Immunotherapy ResistanceGenomeWebNEW YORK (GenomeWeb) – A Massachusetts General Hospital-led team has found evidence of recurrent antigen presentation gene changes in melanoma tumors that fail t… Continue reading

2017-10-26 Michael Zand NEWS

CRISPR Can Now Be Used to Edit Individual Bases – Futurism

Continue reading

2017-10-26 Michael Zand NEWS

BioMarins Gene Therapy for Hemophilia A Continues to Impress – Rare Disease Report (blog)


Futurism

CRISPR Can Now Be Used to Edit Individual Bases
Futurism
CRISPR-Cas9 has been widely heralded as one of the most important scientific developments of recent years, thanks to its capacity to make edits to the human genome. Now, a more precise version of the tool has been developed by a team of scientists from …
Gene-editing tool CRISPR can now manipulate more types of …The Verge
CRISPR 2.0 Is Here, and It’s Way More Precise – MIT Technology …MIT Technology Review
New CRISPR version could make precision medicine even more preciseHealthcare IT News
Genetic Engineering & Biotechnology News –Engadget –WIRED –Science
all 80 news articles »
Continue reading

2017-10-26 Michael Zand NEWS

New CAR-T cell therapy offers hope to lymphoma patients – KABC-TV


Rare Disease Report (blog)

BioMarins Gene Therapy for Hemophilia A Continues to Impress
Rare Disease Report (blog)
FDA has granted Breakthrough Therapy Designation to Biomarin’s gene therapy for hemophilia A, valoctocogene roxaparvovec (BMN 270).
BioMarin Announces Third Quarter 2017 Financial ResultsPR Newswire (press release)

all 4 news articles »

Continue reading

2017-10-26 Michael Zand NEWS

North Texan one of first to receive gene therapy for a rare form of blindness – Dallas News

Dallas NewsNorth Texan one of first to receive gene therapy for a rare form of blindnessDallas NewsWhen he was 9, Mason Two Crow learned he could be legally blind before he turned 18. A few years later, his doctors told him something else: Researchers … Continue reading

2017-10-26 Michael Zand NEWS

Editas Medicine, Inc. (NASDAQ:EDIT) Experiences Light Trading Volume – HugoPress

Key GazetteEditas Medicine, Inc. (NASDAQ:EDIT) Experiences Light Trading VolumeHugoPressCRISPR uses a protein-ribonucleic acid (RNA) complex composed of an enzyme, including either Cas9 (CRISPR associated protein 9) or Cpf1 (CRISPR from Prevotella and … Continue reading

2017-10-26 Michael Zand NEWS
  • 1
  • …
  • 983
  • 984
  • 985
  • 986
  • 987
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

KABC-TV

New CAR–T cell therapy offers hope to lymphoma patients
KABC-TV
Forman told Fata about new research they were doing at City of Hope, called CAR–T cell therapy. Doctors harvested his T cells, ramped them up, then sent them back into his body. “Their sole purpose, the way we’ve engineered them, is to go into the body …